RBC Capital analyst Lisa Walter reiterated an Outperform rating and $30.00 price target on Ocular Therapeutix (NASDAQ: OCUL).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments